SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.948
AS - Asia 10.928
EU - Europa 7.262
SA - Sud America 1.736
AF - Africa 225
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 38.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.481
SG - Singapore 4.256
CN - Cina 2.645
DE - Germania 2.315
BR - Brasile 1.384
IT - Italia 1.268
VN - Vietnam 1.221
HK - Hong Kong 879
UA - Ucraina 863
GB - Regno Unito 549
RU - Federazione Russa 545
TR - Turchia 497
FI - Finlandia 476
FR - Francia 361
BD - Bangladesh 276
JP - Giappone 275
IN - India 240
SE - Svezia 240
PL - Polonia 224
CA - Canada 199
MX - Messico 195
ID - Indonesia 143
AR - Argentina 131
NL - Olanda 113
ZA - Sudafrica 88
IQ - Iraq 85
PK - Pakistan 70
ES - Italia 68
EC - Ecuador 54
VE - Venezuela 44
UZ - Uzbekistan 43
CO - Colombia 42
LT - Lituania 41
MY - Malesia 38
AT - Austria 37
BE - Belgio 36
PH - Filippine 34
SA - Arabia Saudita 31
MA - Marocco 28
AE - Emirati Arabi Uniti 24
CL - Cile 23
TN - Tunisia 21
KE - Kenya 18
JM - Giamaica 17
PE - Perù 17
AL - Albania 16
EG - Egitto 16
IE - Irlanda 16
JO - Giordania 16
PY - Paraguay 15
AU - Australia 14
NP - Nepal 14
CR - Costa Rica 13
RO - Romania 13
TH - Thailandia 13
AZ - Azerbaigian 12
BO - Bolivia 12
CH - Svizzera 12
DZ - Algeria 12
PS - Palestinian Territory 12
UY - Uruguay 12
CZ - Repubblica Ceca 10
ET - Etiopia 10
IL - Israele 10
GR - Grecia 9
KR - Corea 9
LB - Libano 9
CY - Cipro 8
KZ - Kazakistan 8
IR - Iran 7
OM - Oman 7
PA - Panama 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
EU - Europa 6
KG - Kirghizistan 6
LV - Lettonia 6
AM - Armenia 5
GA - Gabon 5
HN - Honduras 5
HU - Ungheria 5
MT - Malta 5
NG - Nigeria 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
GT - Guatemala 4
LK - Sri Lanka 4
MD - Moldavia 4
SV - El Salvador 4
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
HR - Croazia 3
KW - Kuwait 3
MM - Myanmar 3
Totale 38.073
Salva come PNG Salva come JPEG
Città #
Singapore 2.728
Ashburn 2.122
San Jose 1.413
Woodbridge 1.317
Fairfield 1.155
Chandler 1.111
Jacksonville 904
Hong Kong 865
Santa Clara 856
Beijing 850
Houston 815
Ann Arbor 506
Seattle 444
Wilmington 443
New York 402
Ho Chi Minh City 399
Los Angeles 360
Cambridge 359
Munich 318
Dallas 302
Hanoi 296
Izmir 281
Nanjing 265
Tokyo 265
Princeton 227
Addison 216
Lauterbourg 215
Warsaw 215
Helsinki 196
Milan 177
Council Bluffs 168
São Paulo 165
San Diego 156
Ferrara 155
Shanghai 155
Mexico City 130
Boardman 116
Orem 99
Turku 91
London 90
Jakarta 89
Buffalo 85
Shenyang 78
Chicago 77
Chennai 74
Hebei 70
Nanchang 70
Washington 70
Hefei 69
Bremen 67
Denver 64
Montreal 64
Brooklyn 63
Rome 63
Tianjin 58
Toronto 57
Dearborn 56
Johannesburg 54
Changsha 52
Moscow 52
Frankfurt am Main 51
Haiphong 50
Stockholm 49
San Francisco 48
Bologna 47
Da Nang 46
Mountain View 46
Atlanta 44
Phoenix 44
Jiaxing 43
Boston 41
Manchester 40
Rio de Janeiro 39
Falls Church 37
Poplar 37
Tashkent 36
The Dalles 36
Brussels 35
Redwood City 35
Jinan 33
Kunming 33
Amsterdam 31
Guangzhou 31
Hải Dương 31
Nuremberg 30
Baghdad 29
Belo Horizonte 29
Ankara 27
Biên Hòa 27
Lahore 27
Mumbai 25
Ningbo 24
Quito 24
Norwalk 23
New Delhi 22
Zhengzhou 22
Brasília 21
Falkenstein 21
Campinas 20
Curitiba 20
Totale 24.033
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 315
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 302
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 286
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 265
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 249
Circadian profile of plasma calcitonin gene-related peptide in healthy man 241
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 239
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 234
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 229
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 226
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 224
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 220
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 219
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 218
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 216
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Growth hormone induces chemoresistance in breast cancer cells 213
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 211
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 211
Growth hormone excess promotes breast cancer chemoresistance 210
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 210
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 207
Neck paraganglioma and follicular lymphoma: A case report 204
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 201
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 201
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 201
Diurnal rhythm of plasma catecholamines in acromegaly 200
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 200
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 199
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 197
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 194
A new VHL polymorphism in a big family from Ferrara 193
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 191
Efficacy, safety and adherence to treatment of teriparatide: an observational study 190
A tool to predict survival in stage IV entero-pancreatic NEN 190
Effects of octreotide on gallbladder motor function in acromegaly 189
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 187
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 186
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 186
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 185
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 185
Pituitary side effects of old and new drugs. 184
Growth hormone and skeletal muscle function 183
Percutaneous Laser Ablation of Liver Metastases from Neuroendocrine Neoplasm. A Retrospective Study for Safety and Effectiveness 183
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 182
Glucose metabolism alterations in acromegaly 181
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 181
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 179
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 179
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 178
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 177
In vitro testing of new somatostatin analogs on pituitary tumor cells 177
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 177
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 176
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 176
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 176
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 176
Cerebral aneurysm and acromegaly: a case report 175
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 175
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 174
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 174
ASSE GH-IGF-I NELL'INVECCHIAMENTO 174
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 173
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 172
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 172
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 172
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 171
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 171
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 170
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 170
Functional hypothalamic and drug-induced amenorrhea: an overview 170
Densitometria Ossea (DEXA): come interpretarla evitando le trappole 169
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 168
Le alterazioni pressorie nell'acromegalia: fattori umorali 168
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 168
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 167
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 166
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 165
Delta opioid receptor involvement in endocrine pathophysiology 164
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 164
Sistema Simpatoadrenomidollare nei pazienti acromegalici 164
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 164
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 161
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 161
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 160
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 160
Cerebrovascular disease and GH-IGF-i axis function 159
Real-time PCR is useful to detect menin gene deletions 158
Replacement therapy and quality of life improvement in adult GHD patients 158
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 157
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 157
Real-world study of everolimus in advanced progressive neuroendocrine tumors 155
Acromegaly in the elderly patients 155
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 154
Totale 19.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.544
Totale 181.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/20221.981 58 208 114 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/20255.557 157 149 427 183 640 580 206 198 906 687 782 642
2025/202615.902 1.472 611 1.302 1.891 2.491 1.124 1.955 910 1.486 1.783 770 107
Totale 38.492